2:41 PM
Jul 10, 2018
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Colorectal cancer; breast cancer

Patient sample and mouse studies suggest inhibiting CNR2 or promoting MGLL expression could help treat colorectal and breast cancers. In tumor samples from 30 colorectal cancer patients, levels of CNR2 were higher and levels of its negative regulator MGLL were lower in tumor-associated macrophages than in macrophages from adjacent...

Read the full 241 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >